CSIMarket


Aclarion Inc   (ACON)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Aclarion Inc

ACON's Fundamental analysis








Aclarion Inc 's sales fell by -62.74 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 395

Medical Laboratories industry recorded deterioration of revenues by -1.95 %

Aclarion Inc net loss deacreased by in IV. Quarter 2022 year on year, Aclarion Inc net loss increased by -82.53 % in IV. Quarter 2022 year on year,

More on ACON's Growth


Aclarion Inc
reported net loss of -8 millions in the past twelve months.

Company
PE TTM   
Industry
19.6
PE TTM    
Medical Laboratories industry's Price to Sales ratio is at 2.11.


More on ACON's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.92
 Tangible Book Value (Per Share $)

Aclarion Inc
reported net loss of -8 millions in the past twelve months.

Company
PE TTM   
Industry
19.6
PE TTM    
Medical Laboratories industry's Price to Sales ratio is at 2.11.